Insights

Nemotron 3.5 Super VL: near-frontier accuracy at a fraction of the cost

November 4, 2026
10 min read
Yaron David, CTO and Co-Founder of BioRaptor
Yaron David
CTO and Co-founder
A scanned handwritten batch production record, badged Updated with NVIDIA Nemotron 3.5 Super VL, above the BioRaptor fields extracted from it, including product titer, osmolality 295 mOsm/kg, an inoculation event and seed lot SBL-260901-04, with the BioRaptor and NVIDIA logos below
Key results for NVIDIA Nemotron 3.5 Super VL on executed batch records: 88% field accuracy with self-checking vs 90% for a frontier VLM, 97% checkbox accuracy vs 94%, about 1/6 of the frontier API cost per page on two GPUs, and zero fine-tuning across 558 fields

Our collaboration with NVIDIA continues to push the boundaries of AI-powered bioprocess intelligence.

Following our previous work with NVIDIA Nemotron, NVIDIA gave BioRaptor early access to Nemotron 3.5 Super VL ahead of its public release. This allowed us to evaluate the new model on one of the more challenging problems in biopharma: extracting reliable information from executed manufacturing batch records. The model is now publicly available, and below is what we found.

The model has 120 billion total parameters, with 12 billion active during inference. We tested it against a leading frontier vision-language model using real fermentation batch records containing handwritten values, circled options, checkboxes, stamps, and operator sign-offs.

The results

We evaluated 558 fields against human-corrected ground truth.

Bar chart of field-level accuracy on executed batch records, 558 fields: Nemotron 3.5 Super VL 85% vs frontier VLM 86% single-pass, 88% vs 90% with self-checking, 97% vs 94% on checkboxes
  • Single-pass accuracy
    Nemotron 3.5 Super VL: 85%. Frontier model: 86%.
  • With self-checking
    Nemotron 3.5 Super VL: 88%. Frontier model: 90%.
  • Checkbox accuracy
    Nemotron 3.5 Super VL: 97%. Frontier model: 94%.

Nemotron also performed better on operator names in document headers and produced fewer hallucinated values.

All of this was achieved without fine-tuning.

What we learned

Our early access allowed us to experiment with different extraction strategies and identify what really matters:

  • Reasoning is essential
    Disabling reasoning reduced accuracy by more than half.
  • Simple instructions make a difference
    Rules for interpreting handwriting, circled selections, and units improved extraction without customer-specific training.
  • Give the model room to reason
    A 64K-token output budget proved useful.
  • More context isn’t necessarily better
    Providing example images actually reduced accuracy.

Achieving a better combination of accuracy, cost, and privacy

Bar chart of relative cost per page: Nemotron 3.5 Super VL self-hosted on two GPUs costs about 1/6 of a frontier VLM API, and runs inside the customer's VPC

For the test, we ran the model on two GPUs, on AWS using spot instances with costs at approximately $0.003 per page, amounting to around 1/6 of the frontier API cost in our evaluation.

Irrespective of costs, for biomanufacturing, where the process is much of the secret sauce, there is an added benefit: the model can run entirely inside a customer’s own cloud environment (VPC). Sensitive batch records never need to leave that environment for an external model API.

From batch records to process intelligence

At BioRaptor, document extraction is only the beginning. Extracted values are validated against a bioprocess schema, reviewed by users, and connected to sensor data, offline measurements, materials, and process outcomes.

This turns information buried in manufacturing records into structured data scientists can use to investigate variability, compare runs, and improve processes.

Our continued collaboration with NVIDIA helps us bring increasingly capable AI models into practical biopharma workflows, combining frontier-level performance with the control and economics needed for real-world deployment.

If you would like to see batch-record extraction on your own records, book a demo with us and we’ll show you what’s possible.

Yaron David, CTO and Co-Founder of BioRaptor
Yaron David
CTO and Co-founder

Yaron founded BioRaptor out of a life long passion for science and better understanding how things work. Yaron is an MD and holds a PhD in neuroscience and has been developing data intensive platforms throughout his career in both scientific and healthcare settings.

Connect with the author